BETH MCABEE: Open Payments
NPI 1730425604 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 23 payments from 14 companies in 2025. Trend: 2023 $243 · 2024 $558 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| ABBVIE INC. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $30 |
| JAZZ PHARMACEUTICALS INC. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Incyte Corporation | 1 | $24 |
| ARRAY BIOPHARMA INC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: OPDIVO, PLUVICTO, Onivyde, VENCLEXTA, LUTATHERA, DATROWAY, ZEPZELCA, OJJAARA.
Industry payments across IN — which companies pay providers there.
